Asters has advised the European Bank for Reconstruction and Development on a EUR 15 million loan to Yuria-Pharm.
Yuria-Pharm is a Ukrainian pharmaceutical company.
According to Asters, the financing will support the company’s investment plans in both Ukraine and Uzbekistan. In Ukraine, Yuria-Pharm plans to certify its production under the EU Good Manufacturing Practice standard, install solar panels, and carry out critical IT upgrades. In Uzbekistan, the loan will be used to expand production facilities, install solar panels, and improve energy efficiency.
Earlier, in 2020, Asters advised the EBRD on a EUR 25 million financing to Yuria-Pharm (as reported by CEE Legal Matters on July 1, 2020).
The Asters team included Partner Iryna Pokanay, Senior Associate Inna Bondarenko, and Associate Viktoria Zagreba.
Asters did not respond to our inquiry on the matter.